Total results2,176
Search criteria
All records
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| CLN3 | Q13286 | Battenin (Batten disease protein) (Protein CLN3) | Disease related genesHuman disease related genesPotential drug targets | 6 | Neuronal ceroid lipofuscinosisLysosomal disease | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 8 | 0.63 | ||
| CMYA5 | Q8N3K9 | Cardiomyopathy-associated protein 5 (Dystrobrevin-binding protein 2) (Genethonin-3) (Myospryn) (SPRY domain-containing protein 2) (Tripartite motif-containing protein 76) | Predicted intracellular proteins | Other mediation | 8 | 0.63 | ||||
| CNNM3 | Q8NE01 | Metal transporter CNNM3 (Ancient conserved domain-containing protein 3) (Cyclin-M3) | Predicted membrane proteinsTransporters | 4 | Metabolism mediation | 8 | 0.63 | |||
| CR2 | P20023 | Complement receptor type 2 (Cr2) (Complement C3d receptor) (Epstein-Barr virus receptor) (EBV receptor) (CD antigen CD21) | CD markersDisease related genesHuman disease related genes | 1 | Systemic lupus erythematosus | Immune mediation | 8 | 0.63 | ||
| DISP1 | Q96F81 | Protein dispatched homolog 1 | Predicted intracellular proteinsPredicted membrane proteins | 12 | Fusion and delivery mediationMetabolism mediation | 8 | 0.63 | |||
| ERBB2 | P04626 | Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340) | Cancer-related genesCD markersDisease related genes | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 8 | 0.63 | |||
| G3P | P04406 | Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-) | EnzymesEssential proteinsFDA approved drug targets | Muscular atrophyMuscular dystrophy | Clinical-translation mediationImmune mediationMetabolism mediation | 8 | 0.63 | |||
| HLAE | P13747 | HLA class I histocompatibility antigen, alpha chain E (MHC class I antigen E) [Cleaved into: Soluble HLA class I histocompatibility antigen, alpha chain E (sHLA-E)] | Plasma proteinsPredicted membrane proteinsPredicted secreted proteins | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 8 | 0.63 | |||
| IL2RG | P31785 | Cytokine receptor common subunit gamma (Interleukin-2 receptor subunit gamma) (IL-2 receptor subunit gamma) (IL-2R subunit gamma) (IL-2RG) (gammaC) (p64) (CD antigen CD132) | Cancer-related genesCD markersDisease related genes | 1 | SCID | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 8 | 0.63 | ||
| SLAF5 | Q9UIB8 | SLAM family member 5 (Cell surface antigen MAX.3) (Hly9-beta) (Leukocyte differentiation antigen CD84) (Signaling lymphocytic activation molecule 5) (CD antigen CD84) | CD markersPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 8 | 0.63 |